Bioage Labs Inc. Share Price (NASDAQ: BIOA)

Bioage Labs Inc. Stock Performance

as on October 16, 2025 at 1:29 am IST

Day's Low
Day's High
$5.56
Day's Price Range
$5.73
$5.69
2.28%
Downside
0.70%
Upside
52 Week's Low
52 Week's High
$2.88
52-Week Price Range
$26.62
$5.69
49.38%
Downside
367.84%
Upside

Bioage Labs Inc. share price movements today

Previous Close: $5.51
Open: $5.56
Volume: 277.1K
Day's Low - High: $5.56 - $5.73
52 Week Low - High: $2.88 - $26.62

Bioage Labs Inc. Historical Returns

1 Month Return: + 16.12 %
3 Month Return: + 22.89 %
1 Year Return: -76.46 %
3 Year Return: 0 %
5 Year Return: 0 %

Bioage Labs Inc. Stock Fundamentals & Key Indicators

Check Bioage Labs Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$197.5M

EPS (TTM)

-2.0076

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

85925100.00%

Bioage Labs Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioage Labs Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bioage Labs Inc.	NA	$197.5M	NA	NA	0.00%
United Therapeutics Corporation	BUY	$19.5B	NA	16.86	40.36%
Haleon Plc Spon Ads	BUY	$40.8B	NA	20.38	13.81%
Neurocrine Biosciences Inc.	BUY	$13.7B	34.36%	40.87	13.88%
Zoetis Inc.	BUY	$63.0B	-13.1%	24.46	27.83%

Stock Returns calculator for Bioage Labs Inc. Stock including INR - Dollar returns

The Bioage Labs Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bioage Labs Inc. investment value today

Current value as on today

₹28,373

Returns

₹71,627

(-71.63%)

Returns from Bioage Labs Inc. Stock

₹76,458 (-76.46%)

Dollar Returns*

₹4,831 (+4.83%)

Bioage Labs Inc. Stock’s Investor Sentiment and Interest

Search interest for Bioage Labs Inc. Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 16, 2025 to October 16, 2025

Change:24% versus previous 30 day period

Bioage Labs Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	1	2
Gross Profit	-	-	-	-	-	-	-	-	1	2
Operating Income	-11	-13	-9	-13	-12	-15	-24	-25	-16	-24
EBITDA	-10	-15	-12	-18	-11	-13	-22	-20	-16	-21
Interest Expense	0	2	2	2	1	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-17	-14	-20	-12	-13	-23	-21	-12	-21
Income Tax Expense	0	2	-	-	1	0	-	-	-	-
Net Income	-11	-17	-14	-20	-12	-13	-23	-21	-12	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-890.97%	-893.99%

Bioage Labs Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2022	Dec 2023	Dec 2024
Total Revenue	2	1	2	8	14	-	-	-
Gross Profit	0	-4	0	-5	-7	-	-	-
Operating Income	-41	-35	-38	-29	-110	-39	-48	-78
EBITDA	-38	-44	-33	-13	-88	-39	-55	-78
Interest Expense	7	-	-	-	-	0	7	2
Depreciation	-	-	-	-	-	0	0	0
Income Before Tax	-33	-47	-41	-28	-102	-39	-63	-71
Income Tax Expense	0	0	0	0	0	0	7	-71
Net Income	-33	-46	-37	-22	-98	-39	-63	-71
Net Profit Margin	-1246.33%	-3008.45%	-1713.94%	-271.72%	-656.84%	0.00%	0.00%	0.00%

Bioage Labs Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	-14	-20	-12	-13	-23	-21	-12	-21
Operating Cash Flow	-11	-7	-8	-15	-15	-14	-5	-17	-19
Investing Cash Flow	0	0	-	-	0	0	0	-77	-15
Financing Cash Flow	12	0	-1	168	-2	190	24	-1	-1
Change in Cash	1	-7	-9	152	-18	175	19	-96	-37

Bioage Labs Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2022	Dec 2023	Dec 2024
Net Income	-46	-37	-22	-98	-39	-63	-71
Operating Cash Flow	-22	-32	-37	-29	-36	-37	-51
Investing Cash Flow	-	-	-	-	0	0	0
Financing Cash Flow	78	54	47	18	2	34	381
Change in Cash	-32	-44	9	-11	-33	-2	329

Insights on Bioage Labs Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 16.8% return, outperforming this stock by 93.3%
NEGATIVE IMPACT
Price Dip
In the last 1 year, BIOA stock has moved down by -76.5%

About Bioage Labs Inc.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.

Organisation	Bioage Labs Inc.
Headquarters	1445A South 50th Street, Richmond, CA, United States, 94804
CEO	Dr. Kristen Fortney Ph.D.
E-voting on shares	Click here to vote

Key Management of Bioage Labs Inc.

Name	Title
Dr. Kristen Fortney Ph.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Julie Gammelgard	Senior Vice President of People
Mr. BJ Sullivan Ph.D.	Chief Strategy Officer
Dr. Carrie-Lynn Langlais Furr	Senior Vice President of Regulatory Affairs
Mr. Justin Rebo	Senior Vice President of Translational Aging Biology
Mr. Eric Morgen M.D.	Co-Founder, COO & Director
Dr. Paul D. Rubin M.D.	Chief Medical Officer & Executive VP of Research
Dr. Dov A. Goldstein M.B.A., M.D.	Chief Financial Officer
Mr. Rusty Montgomery Ph.D.	Senior Vice President of Research
Dr. Peng Leong M.B.A., Ph.D.	Chief Business Officer & Therapeutic Area Head of Brain Aging

FAQs

What is Bioage Labs Inc. share price today?

Bioage Labs Inc. share price today is $5.69 as on October 16, 2025 at 1:29 am IST at the close of the market. Bioage Labs Inc. share today touched a day high of $5.73 and a low of $5.56.

What is the 52 week high and 52 week low for Bioage Labs Inc. share?

Bioage Labs Inc. share touched a 52 week high of $26.62 on October 22, 2024 and a 52 week low of $2.88 on April 9, 2025. Bioage Labs Inc. stock price today i.e. October 16, 2025 at 1:29 am IST is closed at $5.69,which is 78.63% down from its 52 week high and 97.57% up from its 52 week low.

What is Bioage Labs Inc.'s market capitalisation today?

Bioage Labs Inc. market capitalisation is $0.00T as on October 16, 2025 at 1:29 am IST.

How to invest in Bioage Labs Inc. Stock (BIOA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bioage Labs Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioage Labs Inc. Shares that will get you 0.2636 shares as per Bioage Labs Inc. share price of $5.69 per share as on October 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioage Labs Inc. Stock (BIOA) from India?

Indian investors can start investing in Bioage Labs Inc. (BIOA) shares with as little as ₹87.985 or $1 (as of October 16, 2025 at 3:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Bioage Labs Inc. stock (as per the Rupee-Dollar exchange rate as on October 16, 2025 at 3:43 pm IST). Based on Bioage Labs Inc. share’s latest price of $5.69 as on October 16, 2025 at 1:29 am IST, you will get 1.7575 shares of Bioage Labs Inc.. Learn more about fractional shares .